Literature DB >> 6071477

Fatal ventricular fibrillation following intravenous sodium diphenylhydantoin therapy.

G L Gellerman, C Martinez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6071477

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Intravenous propranolol for cardiac disturbances in relation to halothane anesthesia for cardiovascular surgery.

Authors:  A McClish; D Andrew; A Moisan; Y Morin
Journal:  Can Med Assoc J       Date:  1968-09-07       Impact factor: 8.262

2.  Haemodynamic effects of procainamide and phenytoin at apparent therapeutic plasma levels.

Authors:  E Karlsson; C Sonnhag
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

Review 3.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

Review 4.  Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs.

Authors:  J C DeToledo; R E Ramsay
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

5.  Inotropic actions of lignocaine and phenytoin.

Authors:  B L Kennedy; C Nookhwun; C Sadavongvivad; S Tanchajja
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

Review 6.  Cardiovascular adverse effects of phenytoin.

Authors:  B Guldiken; J Rémi; Soheyl Noachtar
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.